Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call Pharmaceutical Investing
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting Medical Device Investing
New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets for diabetes management Medical Device Investing
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR in Patients with Resectable Head and Neck Squamous Cell Carcinoma Pharmaceutical Investing
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference Medical Device Investing
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure Pharmaceutical Investing